|
Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia |
| |
JE Curtis, HA Messner, R Hasselback, TM Elhakim, and EA McCulloch |
| |
JCO Apr 1 1984: 253–259.
[Abstract]
[PDF]
|
 |
|
Clinical features and results of management of superior vena cava syndrome secondary to lymphoma |
| |
R Perez-Soler, P McLaughlin, WS Velasquez, FB Hagemeister, J Zornoza, JT Manning, LM Fuller, and F Cabanillas |
| |
JCO Apr 1 1984: 260–266.
[Abstract]
[PDF]
|
|
|
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis |
| |
PC Sogani, WF Whitmore, Jr, HW Herr, GJ Bosl, RB Golbey, RC Watson, and JJ DeCosse |
| |
JCO Apr 1 1984: 267–270.
[Abstract]
[PDF]
|
|
|
High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study |
| |
SN Wolff, DH Johnson, JD Hainsworth, and FA Greco |
| |
JCO Apr 1 1984: 271–274.
[Abstract]
[PDF]
|
|
|
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer |
| |
M Rozencweig, W ten Bokkel Huinink, F Cavalli, U Bruntsch, P Dombernowsky, H Host, V Bramwell, G Renard, M Van Glabbeke, and G Decoster |
| |
JCO Apr 1 1984: 275–281.
[Abstract]
[PDF]
|
|
|
Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin |
| |
SE Salmon, L Young, B Soehnlen, and R Liu |
| |
JCO Apr 1 1984: 282–286.
[Abstract]
[PDF]
|
|
|
Relationships of body size with breast cancer |
| |
LA Kalish |
| |
JCO Apr 1 1984: 287–293.
[Abstract]
[PDF]
|
|
|
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung |
| |
R Feld, WK Evans, G DeBoer, IC Quirt, FA Shepherd, JL Yeoh, JF Pringle, DG Payne, JG Herman, and D Chamberlain |
| |
JCO Apr 1 1984: 294–304.
[Abstract]
[PDF]
|
|
|
The natural history of gastric cancer and prognostic factors influencing survival |
| |
AY Bedikian, TT Chen, N Khankhanian, LK Heilbrun, CM McBride, MJ McMurtrey, and GP Bodey |
| |
JCO Apr 1 1984: 305–310.
[Abstract]
[PDF]
|
|
|
Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate |
| |
NE Kemeny, T Ahmed, RA Michaelson, HD Harper, and LC Yip |
| |
JCO Apr 1 1984: 311–315.
[Abstract]
[PDF]
|
|
|
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study |
| |
JM Quagliana, RL Stephens, LH Baker, and JJ Costanzi |
| |
JCO Apr 1 1984: 316–319.
[Abstract]
[PDF]
|
|
|
Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide |
| |
HJ Senn, A Glaus, and I Bachmann-Mettler |
| |
JCO Apr 1 1984: 320–322.
[Abstract]
[PDF]
|
|
| Glucocorticoid receptors in leukemia and lymphoma |
| CD Bloomfield |
|
JCO Apr 1 1984: 323–328.
[PDF]
|
|
| The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia |
| PH Wiernik |
|
JCO Apr 1 1984: 329–335.
[PDF]
|
|
|
Interferons in the treatment of human cancer |
| |
JM Kirkwood and MS Ernstoff |
| |
JCO Apr 1 1984: 336–352.
[Abstract]
[PDF]
|
|
